LoginGet started
Picture of L&K Biomed Co logo

156100 — L&K Biomed Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for L&K Biomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11,832-11,716-13,646-16,233-5,239
Depreciation
Amortisation
Non-Cash Items6,3469,2853,5418,9616,229
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital2,007-1,426-2,220-1,911-4,672
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities0.623-777-10,600-6,881-1,370
Capital Expenditures-933-2,182-459-107-2,099
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items4,4588845,760-2,395-4,315
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities3,525-1,2975,301-2,502-6,413
Financing Cash Flow Items-221—3,1210—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-6,58317816,3537335,629
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3,02926611,197-8,713-2,348